Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 810

1.

Plasma folate, vitamin B-6, vitamin B-12, and risk of breast cancer in women.

Lin J, Lee IM, Cook NR, Selhub J, Manson JE, Buring JE, Zhang SM.

Am J Clin Nutr. 2008 Mar;87(3):734-43.

2.

Plasma folate, vitamin B6, vitamin B12, homocysteine, and risk of breast cancer.

Zhang SM, Willett WC, Selhub J, Hunter DJ, Giovannucci EL, Holmes MD, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2003 Mar 5;95(5):373-80.

PMID:
12618502
3.

Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.

Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, Ma J.

J Natl Cancer Inst. 2005 May 4;97(9):684-92.

PMID:
15870439
4.

Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.

Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.

J Natl Cancer Inst. 2006 Oct 4;98(19):1406-15.

PMID:
17018787
5.

Folate and other one-carbon metabolism-related nutrients and risk of postmenopausal breast cancer in the Cancer Prevention Study II Nutrition Cohort.

Stevens VL, McCullough ML, Sun J, Gapstur SM.

Am J Clin Nutr. 2010 Jun;91(6):1708-15. doi: 10.3945/ajcn.2009.28553. Epub 2010 Apr 21.

6.

Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.

PMID:
15840882
7.

Long-term dietary calcium intake and breast cancer risk in a prospective cohort of women.

Larsson SC, Bergkvist L, Wolk A.

Am J Clin Nutr. 2009 Jan;89(1):277-82. doi: 10.3945/ajcn.2008.26704. Epub 2008 Dec 3.

8.

Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.

Missmer SA, Eliassen AH, Barbieri RL, Hankinson SE.

J Natl Cancer Inst. 2004 Dec 15;96(24):1856-65.

PMID:
15601642
9.

Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.

J Natl Cancer Inst. 2005 May 18;97(10):755-65.

PMID:
15900045
10.

Plasma cysteinylglycine levels and breast cancer risk in women.

Lin J, Manson JE, Selhub J, Buring JE, Zhang SM.

Cancer Res. 2007 Dec 1;67(23):11123-7.

11.

A prospective study on folate, B12, and pyridoxal 5'-phosphate (B6) and breast cancer.

Wu K, Helzlsouer KJ, Comstock GW, Hoffman SC, Nadeau MR, Selhub J.

Cancer Epidemiol Biomarkers Prev. 1999 Mar;8(3):209-17.

12.

Dietary folate, vitamin B6, vitamin B12 and methionine intake and the risk of breast cancer by oestrogen and progesterone receptor status.

Zhang CX, Ho SC, Chen YM, Lin FY, Fu JH, Cheng SZ.

Br J Nutr. 2011 Sep;106(6):936-43. doi: 10.1017/S0007114511001140. Epub 2011 May 16.

PMID:
21736840
13.

Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.

Han J, Hankinson SE, Zhang SM, De Vivo I, Hunter DJ.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):520-4.

14.

Intake of dairy products, calcium, and vitamin d and risk of breast cancer.

Shin MH, Holmes MD, Hankinson SE, Wu K, Colditz GA, Willett WC.

J Natl Cancer Inst. 2002 Sep 4;94(17):1301-11.

PMID:
12208895
15.

Plasma folate concentrations are positively associated with risk of estrogen receptor beta negative breast cancer in a Swedish nested case control study.

Ericson U, Borgquist S, Ivarsson MI, Sonestedt E, Gullberg B, Carlson J, Olsson H, Jirström K, Wirfält E.

J Nutr. 2010 Sep;140(9):1661-8. doi: 10.3945/jn.110.124313. Epub 2010 Jun 30.

16.

Predicting risk of breast cancer in postmenopausal women by hormone receptor status.

Chlebowski RT, Anderson GL, Lane DS, Aragaki AK, Rohan T, Yasmeen S, Sarto G, Rosenberg CA, Hubbell FA; Women's Health Initiative Investigators.

J Natl Cancer Inst. 2007 Nov 21;99(22):1695-705. Epub 2007 Nov 13.

PMID:
18000216
17.

Association between family history of cancer and breast cancer defined by estrogen and progesterone receptor status.

Tutera AM, Sellers TA, Potter JD, Drinkard CR, Wiesner GL, Folsom AR.

Genet Epidemiol. 1996;13(2):207-21.

PMID:
8722747
18.

Plasma prolactin concentrations and risk of postmenopausal breast cancer.

Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE.

Cancer Res. 2004 Sep 15;64(18):6814-9.

19.

Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.

Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS.

J Natl Cancer Inst. 2005 Nov 16;97(22):1688-94.

PMID:
16288122
20.

Recreational physical activity and risk of postmenopausal breast cancer based on hormone receptor status.

Bardia A, Hartmann LC, Vachon CM, Vierkant RA, Wang AH, Olson JE, Sellers TA, Cerhan JR.

Arch Intern Med. 2006 Dec 11-25;166(22):2478-83.

PMID:
17159013

Supplemental Content

Support Center